|
Age in years, median (range)
|
66.1 (22.8, 91.3)
|
|
Gender males/females—ratio
|
169/142
|
|
Location primary tumour
|
|
Colon, n (%)
|
205 (65.9)
|
|
Rectum, n (%)
|
101 (32.5)
|
|
Combined, n (%)
|
5 (1.6)
|
|
Synchronous metastasesa, n (%)
|
157 (50.5)
|
|
Disease-free intervalb in months, median (range)
|
4.2 (−11, 131)
|
|
Resections, n
|
311
|
|
Hemihepatectomy/lobectomy, n (%)
|
137 (44.1)
|
|
Wedge/segment resections, n (%)
|
174 (55.9)
|
|
Simultaneous radio frequency ablation, n (%)
|
12 (3.9)
|
|
Two-stage resections with PVL, n (%)
|
3 (1.0)
|
|
Simultaneous colorectal cancer surgery, n (%)
|
18 (5.8)
|
|
R1 resections (<1 mm)
|
63 (20.3)
|
|
Extent of RM in millimeter, median (range)
|
4 (0–50)
|
|
Number of metastases, median (range)
|
2 (1, 12)
|
|
Metastases diameter in centimeter, median (range)
|
3.0 (0.2, 15.0)
|
|
Bilobar metastases, n (%)
|
108 (34.7)
|
|
Number of procedures/patient (1/2/3/4/5)
|
254/42/11/3/1
|
|
Morbidity (Clavien-Dindo score 1/2/3/4/5)
|
19/28/52/5/6
|
|
Outcome of chemotherapy (RECIST criteria)
|
|
Partial response, n (%)
|
63 (56.2)
|
|
Stable disease, n (%)
|
42 (37.5)
|
|
Progression, n (%)
|
5 (4.4)
|
|
Unknown, n (%)
|
2 (1.8)
|
